Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03162887
Other study ID # 14G.62
Secondary ID
Status Completed
Phase N/A
First received May 19, 2017
Last updated May 19, 2017
Start date February 6, 2014
Est. completion date August 11, 2016

Study information

Verified date May 2017
Source Thomas Jefferson University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot clinical trial studies how well an educational module and decision counseling program works in increasing mammography screening rates in formerly homeless women with serious mental illness. An educational module and decision counseling program may be an effective tool and have the potential to help with early detection and treatment.


Description:

PRIMARY OBJECTIVES:

I. Increase mammography screening rates in women age 40 and over with experiences of homelessness and serious mental illness (SMI).

II. Increase knowledge, decease psychological distress, and advance decision stage and intention to get a mammogram in study participants.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date August 11, 2016
Est. primary completion date July 12, 2014
Accepts healthy volunteers No
Gender Female
Age group 40 Years and older
Eligibility Inclusion Criteria:

- 30 formerly homeless women with a diagnosis of a serious mental illness in the Pathways to Housing or Project HOME supportive housing programs

- Only women that have never received a mammogram are eligible to participate (self-report)

- Participants must be willing to participate in all aspects of research

Exclusion Criteria:

- Participants cannot be decisionally impaired, actively psychotic, or have unstable mental illness that prevents participation in the decisional counseling session

- Women who have had a mammogram will be excluded from the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Educational Intervention
Receive a research team member-led breast cancer and mammogram educational module
Counseling
Undergo a web-based decision counseling session
Informational Intervention
Receive a "next steps" document

Locations

Country Name City State
United States Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Sidney Kimmel Cancer Center at Thomas Jefferson University American Cancer Society, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in decisional conflict score assessed by pre- and post-intervention survey Will estimate the mean pre/post change, along with a 95% confidence interval, and will test this change via a paired t-test. Will use linear regression to assess what factors (including socio-demographics and decision counseling score) are associated with the change. Baseline up to 1 month
See also
  Status Clinical Trial Phase
Suspended NCT02243397 - Molecular and Cellular Analysis of Breast Cancer
Completed NCT02601027 - Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA Phase 3
Completed NCT03018080 - Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer Phase 2
Completed NCT01970670 - Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer